MiR-192 confers Cisplatin resistance by targeting Bim in lung cancer

Chinese Journal of Lung Cancer

Volumn 17, Issue 5, 2014, Pages 384-390

  Zhang, Fang ^a   Li, Yang ^a   Wu, Heng ^a   Qi, Kang ^a   You, Jiacong ^a   Li, Xuebing ^a   Zu, Lingling ^a   Pan, Zhenhua ^a   Wang, Yuli ^a   Li, Yongwen ^a   Li, Ying ^a   Wang, Min ^a   Shen, Wang ^a   Zhou, Qinghua ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

Bim; Lung neoplasms; miR 192; miRNA microarray; RT PCR

Indexed keywords

BIM PROTEIN; CISPLATIN; MICRORNA 192; 3' UNTRANSLATED REGION; APOPTOSIS REGULATORY PROTEIN; BCL-2-LIKE PROTEIN 11; MEMBRANE PROTEIN; MICRORNA; MIRN192 MICRORNA, HUMAN; ONCOPROTEIN;

APOPTOSIS; ARTICLE; CHEMOSENSITIVITY; DOWN REGULATION; GENE EXPRESSION; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IC 50; LUCIFERASE ASSAY; LUNG CANCER; MICROARRAY ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; 3' UNTRANSLATED REGION; DRUG RESISTANCE; GENE EXPRESSION REGULATION; GENETICS; LUNG NEOPLASMS; METABOLISM; TUMOR CELL LINE;

3' UNTRANSLATED REGIONS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CELL LINE, TUMOR; CISPLATIN; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; MEMBRANE PROTEINS; MICRORNAS; PROTO-ONCOGENE PROTEINS;

EID: 84922481917     PISSN: 10093419     EISSN: 19996187     Source Type: Journal    
DOI: 10.3779/j.issn.1009-3419.2014.05.04     Document Type: Article

References (15)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin, 2013, 63(1): 11-30.
2. Tsuchiya S, Okuno Y, Tsujimoto G. MicroRNA: biogenetic and functional mechanisms and involvements in cell differentiation and cancer. J Pharmacol Sci, 2006, 101(4): 267-270.
3. Yan L-X, Huang X-F, Shao Q, et al. MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis. RNA, 2008, 14(11): 2348-2360.
4. Chen CZ. MicroRNAs as oncogenes and tumor suppressors. N Engl J Med, 2005, 353(17): 1768-1771.
5. Fujita Y, Kojima K, Hamada N, et al. Effects of miR-34a on cell growth and chemoresistance in prostate cancer PC3 cells. Biochem Biophys Res Commun, 2008, 377(1): 114-119.
6. Hamano R, Miyata H, Yamasaki M, et al. Overexpression of miR-200c induces chemoresistance in esophageal cancers mediated through activation of the akt signaling pathway. Clin Cancer Res, 2011, 17(9): 3029-3038.
7. Luzna P, Gregar J, Uberall I, et al. Changes of microRNAs-192, 196a and 203 correlate with Barrett's esophagus diagnosis and its progression compared to normal healthy individuals. Diagn Pathol, 2011, 6: 114.
8. Pichiorri F, Suh S-S, Rocci A, et al. Downregulation of p53-inducible microRNAs 192, 194, and 215 Impairs the p53/MDM2 autoregulatory loop in multiple myeloma development. Cancer Cell, 2010, 18(4): 367-381.
9. Jin Z, Selaru FM, Cheng Y, et al. MicroRNA-192 and-215 are upregulated in human gastric cancer in vivo and suppress ALCAM expression in vitro. Oncogene, 2011, 30(13): 1577-1585.
10. Feng S, Cong S, Zhang X, et al. MicroRNA-192 targeting retinoblastoma 1 inhibits cell proliferation and induces cell apoptosis in lung cancer cells. Nucleic Acids Res, 2011, 39(15): 6669-6678.
11. Boni V, Bitarte N, Cristobal I, et al. miR-192/miR-215 influence 5-Fluorouracil resistance through cell cycle-mediated mechanisms complementary to its post-transcriptional thymidilate synthase regulation. Mol Cancer Ther, 2010, 9(8): 2265-2275.
12. Akiyama T, Dass CR, Choong PF. Bim-targeted cancer therapy: a link between drug action and underlying molecular changes. Mol Cancer Ther, 2009, 8(12): 3173-3180.
13. Wang J, Zhou JY, Wu GS. Bim protein degradation contributes to cisplatin resistance. J Biol Chem, 2011, 286(25): 22384-22392.
14. Romano G, Acunzo M, Garofalo M, et al. MiR-494 is regulated by ERK1/2 and modulates TRAIL-induced apoptosis in non-small-cell lung cancer through BIM down-regulation. Proc Natl Acad Sci U S A, 2012, 109(41): 16570-16575.
15. Yan HJ, Liu WS, Sun WH, et al. miR-17-5p inhibitor enhances chemosensitivity to gemcitabine via upregulating Bim expression in pancreatic cancer cells. Dig Dis Sci, 2012, 57(12): 3160-3167.